InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
10
T+90 hit rate
50%
T+90 mean return
+4.0%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Chopas James George, VP/Chief Accounting Officer. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 28 filings have been published. Split: 0 buy · 10 sells. Total volume traded: €204k. History available since 30 August 2021. The latest transaction was filed on 17 March 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations28 total
65,955 sharesCommon StockSEC:0001193125-26-224627
65,955 sharesCommon StockSEC:0001193125-26-224627:0
183 shares@ US$24.82371.4% of flowCommon StockSEC:0001127602-25-009738:0
▼
1,096 shares@ US$30.425511.1% of flowCommon StockSEC:0001127602-25-001829:0
▼
715 shares@ US$29.95827.2% of flowCommon StockSEC:0001127602-25-001614:0
12,591 shares0Common StockSEC:0001127602-25-001614:1
▼
783 shares@ US$28.70217.6% of flowCommon StockSEC:0001127602-25-001184:0
192 shares@ US$36.2062.2% of flowCommon StockSEC:0001127602-24-024074:0
▼
550 shares@ US$39.4916.8% of flowCommon StockSEC:0001127602-24-023392:0
▼
184 shares@ US$56.4613.3% of flowCommon StockSEC:0001127602-24-010416:0
▼
1,061 shares@ US$64.99621.9% of flowCommon StockSEC:0001127602-24-001928:0
8,312 shares0Common StockSEC:0001127602-24-001441:0
132 shares@ US$46.03622.0% of flowCommon StockSEC:0001127602-23-026188:0
2,500 shares0Common StockSEC:0001127602-23-024308:0
▼
551 shares@ US$41.2267.2% of flowCommon StockSEC:0001127602-23-023568:0
4,044 shares0Common StockSEC:0000899243-23-005785:0
●
919 shares@ US$52.0515.3% of flowCommon StockSEC:0001127602-23-002111:0
9,621 shares0Common StockSEC:0001127602-23-001491:0
130 shares@ US$58.002.7% of flowCommon StockSEC:0001127602-22-024299:0
●
558 shares@ US$58.8411.3% of flowCommon StockSEC:0001127602-22-021810:0
10,657 shares0Common StockSEC:0000899243-22-005090:0
10,657 shares0Common StockSEC:0000899243-22-005090
6,974 shares0Common StockSEC:0001127602-22-002056:0
6,974 shares0Common StockSEC:0001127602-22-002056
882 shares0Common StockSEC:0001127602-21-027699
25 of 28 declarations
About Chopas James George
James George Chopas is the Vice President and Chief Accounting Officer at Apellis Pharmaceuticals, Inc. In this role, he is responsible for managing the company's finances and accounting. His expertise in accounting is essential to ensuring financial compliance and transparency in operations.
